Literature DB >> 30359576

VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma.

Thibault Kervarrec1, Pauline Gaboriaud2, Anne Tallet3, Valérie Leblond2, Francoise Arnold2, Patricia Berthon2, Sophie Schweinitzer4, Thibaut Larcher5, Serge Guyétant6, David Schrama4, Roland Houben4, Mahtab Samimi7, Antoine Touzé2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30359576     DOI： 10.1016/j.jid.2018.08.029

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

1.  Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma.

Authors:  Yiyi Feng; Xin Song; Renbing Jia
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

2.  Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma.

Authors:  Benjamin Sundqvist; Sami Kilpinen; Tom Böhling; Virve Koljonen; Harri Sihto
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

Review 3.  Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.

Authors:  Karolina Stachyra; Monika Dudzisz-Śledź; Elżbieta Bylina; Anna Szumera-Ciećkiewicz; Mateusz J Spałek; Ewa Bartnik; Piotr Rutkowski; Anna M Czarnecka
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

Review 4.  Merkel Cell Carcinoma.

Authors:  Elena Dellambra; Maria Luigia Carbone; Francesca Ricci; Francesco Ricci; Francesca Romana Di Pietro; Gaia Moretta; Sofia Verkoskaia; Elisa Feudi; Cristina M Failla; Damiano Abeni; Luca Fania
Journal:  Biomedicines       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.